LORATADINE; PSEUDOEPHEDRINE SULFATE | N020470 | BAYER HEALTHCARE LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Blue Cross of California - Citizen Petition FDA-1998-P-0254 Blue Cross of California, filed under 21 CFR 10.30, petitioned the FDA to convert six prescription antihistamine medications—Allegra, Allegra-D, Claritin, Claritin-D, Claritin-D 24 Hour, and Zyrtec—to over-the-counter status, arguing these selective antihistamines are safer than currently available | Other | 2009-04-30 | Open | — |
Citizen Petition from Strides, Inc. FDA-2006-P-0087 Strides, Inc. filed this citizen petition requesting that the FDA take action regarding loratadine products, specifically concerning the Orange Book listings and regulatory status of various loratadine formulations including tablets, syrups, and suspensions marketed under names such as Claritin and | Other | 2009-04-20 | Denied | Strides, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.